Search

Search Results
Results 8351 - 8360 of 8408 for allergy
  • Moxonidine GX
    Drug - 17 Feb 2022
    Consumer Medicine Information (CMI) about Moxonidine GX intended for persons living in Australia.
  • Teveten Plus
    Drug - 16 Feb 2022
    Consumer Medicine Information (CMI) about Teveten Plus intended for persons living in Australia.
  • DBL Promethazine Hydrochloride
    Drug - 18 Jan 2022
    Consumer Medicine Information (CMI) about DBL Promethazine Hydrochloride intended for persons living in Australia.
  • Mabcampath
    Drug - 10 Jan 2022
    Consumer Medicine Information (CMI) about Mabcampath intended for persons living in Australia.
  • Lorviqua
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Lorviqua intended for persons living in Australia.
  • Madopar
    Drug - 25 Nov 2021
    Consumer Medicine Information (CMI) about Madopar intended for persons living in Australia.
  • Champix
    Drug - 22 Nov 2021
    Consumer Medicine Information (CMI) about Champix intended for persons living in Australia.
  • Acnatac
    Drug - 18 Nov 2021
    Consumer Medicine Information (CMI) about Acnatac intended for persons living in Australia.
  • DBL Magnesium Sulfate Concentrated Injection
    Drug - 7 Nov 2021
    Consumer Medicine Information (CMI) about DBL Magnesium Sulfate Concentrated Injection intended for persons living in Australia.
  • Hospira Levetiracetam Concentrate for IV infusion
    Drug - 1 Nov 2021
    Consumer Medicine Information (CMI) about Hospira Levetiracetam Concentrate for IV infusion intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback